Specializing in Pharmaceuticals & Biotechnology info@mattsonjack.com
 

EpiDatabase® – now available in Brazil, Russia, India and China. Use the info@mattsonjack.com link above to contact us for more information...

MATTSONJACK HOME CONSULTING SERVICES PRODUCTS CASE STUDIES ABOUT MATTSONJACK WORLDWIDE
 
MJG Home > Products > Leading Indicator

Products

 Epi Database®
 Comorbidity Database™
 Forecast Architect®
 CancerMPact®
 CancerNSight™
 Supportive Care
Perspectives™

Oncology Marketing
Strategies™

Future Focus™

 

The Mattson Jack Group's Leading Indicator tracks changes in New Prescription VELOCITY on a weekly basis. Velocity is the change in New Prescriptions, and it is one of the most sensitive measures for predicting future market share changes. Leading Indicator™ can be used to identify potential competitive shifts in the market before significant share changes occur.

MattsonJack is uniquely qualified to help identify the drivers of competitive changes and, more importantly, how to respond. Our core competencies in promotional response analytics, primary market research, and scientific and commercial assessments can be applied to identify major drivers of brand success and to help track the impact of changes for your brand...and key competitors.

MattsonJack currently provides Leading Indicator™ complementary analyses on the following select therapeutic classes:

For more information or to be added to the distribution for Leading Indicator updates, e-mail Leading Indicator
 
 
©2005 The Mattson Jack Group, Inc. All rights reserved.
a WPP company
CONSULTING SERVICES  |  PRODUCTS  |  CASE STUDIES   |  CONTACT US   |  ABOUT MATTSONJACK
Tel: (314) 469-7600 / (800) 467-7606        Fax: (314) 469-6794        info@mattsonjack.com
Associate Member  
EphMRA logo
MJG Analytics MJG Corporate Development Davinci Oncology The Mattson Jack Group MJG Site Map Contact MJG